Use the column sorting, search filtering, and pagination tools to find and select federal funding opportunities below.
Opportunity | Posted | Closing |
---|---|---|
Agency: CGH | 02/19/21 | 04/20/21 |
Telehealth Centers of Excellence Agency: HRSA | 02/19/21 | 04/20/21 |
Agency: NIH Institutions: NCI | 02/19/21 | 06/02/21 |
Agency: CGH | 02/18/21 | 04/19/21 |
ROSES 2021: Arctic Radiation-Cloud-Aerosol-Surface Interaction Experiment Agency: HQ | 02/12/21 | 10/15/21 |
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) Agency: NIH Institutions: NIHNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNIMHDNLMNCCIHNCATSORIPNCI | 02/10/21 | 01/07/24 |
DoD Lung Cancer, Concept Award Agency: AMRAA | 02/09/21 | 04/20/21 |
DoD Lung Cancer, Career Development Award Agency: AMRAA | 02/09/21 | 04/20/21 |
Human Immunology Project Consortium (U19 Clinical Trial Optional) Agency: NIH Institutions: NIAID | 02/08/21 | 06/04/21 |
Human Immunology Project Consortium (HIPC) Coordinating Center (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID | 02/08/21 | 06/04/21 |
Agency: NIH Institutions: NICHD | 02/08/21 | 06/18/21 |
CDMRP Ovarian Cancer Proteogenomics Research Award Agency: AMRAA | 02/08/21 | 07/08/21 |
CDMRP Ovarian Cancer Clinical Translational Research Award Agency: AMRAA | 02/08/21 | 07/08/21 |
CDMRP Ovarian Cancer Investigator-Initiated Research Award Agency: AMRAA | 02/08/21 | 07/08/21 |
CDMRP Ovarian Cancer, Ovarian Cancer Academy Award Agency: AMRAA | 02/08/21 | 07/08/21 |
CDMRP Ovarian Cancer Pilot Award Agency: AMRAA | 02/08/21 | 07/08/21 |
Agency: NIH Institutions: OPPNETNEINIANICHDNIDCRNIDANIMHNINDSNINRNIMHDNCCIHNCIOBSSR | 02/01/21 | 03/17/21 |
Agency: NIH Institutions: OPPNETNEINIANIAMSNICHDNIDCRNIDANIMHNINDSNINRNIMHDNCCIHNCIOBSSR | 02/01/21 | 03/17/21 |
Promoting Cancer Surveillance Workforce, Education, and Data Use Agency: NCCDPHP | 01/18/21 | 03/30/21 |
Agency: NCIRD | 01/12/21 | 03/22/21 |
Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID | 01/12/21 | 06/04/21 |
Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAIDNIEHS | 01/12/21 | 06/04/21 |
Agency: NIH Institutions: NIDANIAAANIAMSNIMHNCCIH | 01/11/21 | 03/26/21 |
Agency: NSF | 01/08/21 | 12/31/21 |
Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed) Agency: NIH Institutions: ORIP | 01/08/21 | 01/07/24 |
DoD Breast Cancer, Breakthrough Award Level 4 Agency: AMRAA | 01/06/21 | 06/23/21 |
DoD Breast Cancer, Breakthrough Award Level 3 Agency: AMRAA | 01/06/21 | 06/23/21 |
DoD Breast Cancer, Transformative Breast Cancer Consortium Award Agency: AMRAA | 01/06/21 | 06/23/21 |
DoD Breast Cancer, Innovator Award Agency: AMRAA | 01/06/21 | 06/23/21 |
DoD Breast Cancer, Era of Hope Scholar Award Agency: AMRAA | 01/06/21 | 03/25/21 |
DoD Breast Cancer, Breakthrough Award Levels 1 and 2 Agency: AMRAA | 01/06/21 | 03/25/21 |
Agency: NIH Institutions: FICNCI | 01/04/21 | 03/08/23 |
International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required) Agency: NIH Institutions: FICNCI | 01/04/21 | 03/08/23 |
Music and Health: Understanding And Developing Music Medicine (R01 Clinical Trial Optional) Agency: NIH Institutions: NINDSNEINIANIAAANIDCRNIDANIMHNINRNIMHDNCCIHNCIOBSSR | 12/23/20 | 02/05/23 |
Agency: HHSCDCERA | 12/21/20 | 03/03/21 |
Partnering and Communicating Together Agency: NCHHSTP | 12/18/20 | 04/05/21 |
Aging Effects on Osteoimmunology (R01 Clinical Trials Not Allowed) Agency: NIH Institutions: NIA | 12/10/20 | 06/15/21 |
Cellular Cancer Biology Imaging Research (CCBIR) Program (U54, Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 12/09/20 | 03/18/21 |
Agency: NIH Institutions: NCI | 12/02/20 | 11/18/21 |
Agency: NIH Institutions: NCI | 12/02/20 | 11/17/21 |
Agency: NIH Institutions: NCI | 12/02/20 | 11/17/21 |
Agency: NIH Institutions: NCI | 12/02/20 | 11/17/21 |
Agency: NIH Institutions: NCI | 12/02/20 | 11/17/21 |
Agency: NIH Institutions: NCI | 12/02/20 | 11/17/21 |
Agency: NIH Institutions: NCI | 12/02/20 | 11/17/21 |
Center of Excellence (COE) Radiation Effect in Electronic Materials, Circuits, Devices, and Systems Agency: AFOSR | 12/01/20 | 03/31/21 |
Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINHGRI | 11/25/20 | 03/24/21 |
Agency: NIH Institutions: NCI | 11/24/20 | 09/29/21 |
Agency: NIH Institutions: NCI | 11/24/20 | 09/29/21 |
Agency: NIH Institutions: NCI | 11/24/20 | 09/29/21 |
Agency: NIH Institutions: NCI | 11/24/20 | 09/29/21 |
Agency: NIH Institutions: NCI | 11/24/20 | 09/29/21 |
Agency: NIH Institutions: NCI | 11/24/20 | 09/29/21 |
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) Agency: NIH Institutions: NIANIAMSNIDCRNIDDKNIMHNINDSNCI | 11/23/20 | 01/07/24 |
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) Agency: NIH Institutions: NIANIAMSNIDCRNIDDKNINDSNCI | 11/23/20 | 01/07/24 |
Agency: NIH Institutions: NCI | 11/20/20 | 09/28/21 |
Agency: NIH Institutions: NCI | 11/20/20 | 09/29/21 |
Agency: NIH Institutions: NCI | 11/20/20 | 09/29/21 |
Agency: NIH Institutions: NCI | 11/20/20 | 09/29/21 |
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science Agency: NSF | 11/20/20 | 11/10/21 |
Reproducible Cells and Organoids via Directed- Differentiation Encoding Agency: NSF | 11/20/20 | 05/18/21 |
Agency: HQ | 11/17/20 | 03/11/21 |
Agency: NIH Institutions: NCI | 11/17/20 | 01/07/24 |
Agency: NIH Institutions: NCI | 11/17/20 | 01/07/24 |
Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 11/17/20 | 01/07/24 |
Agency: NIH Institutions: NIMHDNIAAANIEHSNCIOBSSR | 11/17/20 | 01/07/23 |
Agency: NIH Institutions: NIMHDNIANIAAANIEHSNCI | 11/17/20 | 01/07/23 |
Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPSGMRO | 11/16/20 | 05/07/23 |
Agency: NIH Institutions: NIDANIAAANCI | 11/16/20 | 11/15/23 |
Agency: NIH Institutions: NIDDK | 11/13/20 | 03/03/21 |
Agency: NIH Institutions: NCI | 11/12/20 | 01/07/24 |
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) Agency: NIH Institutions: NCI | 11/10/20 | 01/07/24 |
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINCCIHNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIMHNIMHDNINDSNINRNLMORIPORWH | 11/09/20 | 12/28/23 |
Agency: NIH Institutions: NCINCCIHNEINIANIAAANIAMSNICHDNIDCDNIDCRNIDANIEHSNIMHNIMHDNINDSNINRNLMORWH | 11/09/20 | 12/28/23 |
Agency: NIH Institutions: NCINHLBINIAAANIAIDNIDDK | 11/05/20 | 09/30/23 |
Agency: NIH Institutions: NCCIHNCINEINHGRINHLBINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDDKNIEHSNIMHNIMHDNINRNINDSNLMORIPNIDANIBIBNIGMS | 10/28/20 | 09/07/23 |
Agency: NIH Institutions: NCCIHNCINEINHGRINHLBINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIEHSNIGMSNIMH | 10/26/20 | 09/07/23 |
Agency: NIH Institutions: NCCIHNCINEINHLBINIANIAAANIAIDNICHDNIDCDNIDCRNIDDKNIEHSNIMHORIP | 10/26/20 | 09/07/23 |
Agency: NIH Institutions: NCCIHNCINHLBINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIEHSNIGMSNIMHNINDSNLMORIP | 10/26/20 | 12/08/23 |
Agency: NIH Institutions: NCCIHNCINEINHGRINHLBINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDDKNIEHSNIMHNIMHDNINRNINDSNLMORIP | 10/21/20 | 09/07/23 |
Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPODPOBSSRODSORWH | 10/13/20 | 10/07/23 |
Agency: NIH Institutions: NCI | 10/13/20 | 10/10/23 |
Agency: NIH Institutions: NCI | 10/13/20 | 10/10/23 |
Agency: NIH Institutions: NCINIDCR | 09/28/20 | 01/07/24 |
Department of Defense HIV/AIDS Prevention Program Agency: AMRAA | 09/24/20 | 09/23/22 |
Agency: NIH Institutions: NCI | 09/23/20 | 12/14/21 |
Agency: NIH Institutions: NCIODP | 09/15/20 | 01/18/22 |
Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional) Agency: NIH Institutions: NCIODP | 09/04/20 | 09/07/23 |
Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional) Agency: NIH Institutions: NCIODP | 09/04/20 | 09/07/23 |
Agency: NIH Institutions: NCI | 08/28/20 | 10/13/21 |
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI | 08/24/20 | 07/20/22 |
Research to Improve Native American Health (R21 Clinical Trials Optional) Agency: NIH Institutions: NIDANIAAANIAMSNIDCRNIEHSNIMHNINRNIMHDNLMNCCIHNCATSNCIOBSSR | 08/17/20 | 09/07/23 |
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDANHLBINIAAANIAIDNIAMSNIBIBNIDCRNIEHSNIMHNINRNIMHDNLMNCIOBSSR | 08/17/20 | 09/07/23 |
Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 08/13/20 | 05/04/23 |
Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 08/05/20 | 11/09/22 |
2020 Human Exploration Research Opportunities (HERO) Agency: JSC | 07/31/20 | 07/30/21 |
Agency: NIH Institutions: NCINHGRI | 07/30/20 | 07/08/21 |
Agency: NIH Institutions: ODSNCINIDDKNIEHSNCCIH | 07/30/20 | 04/15/22 |
Ethical, Legal and Social Implications (ELSI) (Research R01 Clinical Trial Optional) Agency: NIH Institutions: NHGRINCINEINHLBINIANIEHSNIMHNIMHDNINDSOBSSR | 07/28/20 | 07/19/23 |
Agency: NIH Institutions: NHGRINCINEINIANIEHSNIMHNINDSOBSSR | 07/28/20 | 07/19/23 |
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03) Clinical Trial Optional) Agency: NIH Institutions: NHGRIFICNCINIANIEHSNIMHOBSSR | 07/28/20 | 07/19/23 |
Fertility Status as a Marker for Overall Health (R01 Clinical Trial Optional) Agency: NIH Institutions: NICHDNIEHSNCIODPORWH | 07/23/20 | 06/19/23 |
Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NICHDNIEHSNCIODPORWH | 07/23/20 | 06/19/23 |
Agency: NIH Institutions: NCINHGRINIDCR | 07/22/20 | 09/07/22 |
Agency: NIH Institutions: NCINHGRINIDCR | 07/22/20 | 09/07/22 |
Agency: NIH Institutions: NCINIDCDNIMH | 07/20/20 | 01/07/23 |
Agency: NIH Institutions: NCCIHNIANIAAANIMHNCIOBSSR | 07/15/20 | 06/19/23 |
Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIP | 07/14/20 | 04/05/21 |
Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANICHDNIDCDNIDDKNIDANIEHSNIGMSNIMHNINRNIMHDNCCIH | 07/13/20 | 04/05/21 |
Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANICHDNIDCDNIDANIEHSNIGMSNIMHNINRNIMHDNCCIH | 07/13/20 | 04/05/21 |
Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIP | 07/13/20 | 04/05/21 |
Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIBIBNIDCDNIDCRNIDDKNIEHSNIGMSNIMHNLMNCCIHNCATS | 07/10/20 | 04/05/22 |
Agency: NIH Institutions: ODSNCINEINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIEHSNIMHDFICNCCIHORIP | 06/09/20 | 04/15/23 |
Agency: NIH Institutions: OPPNETNIAAANIEHSNIMHNIMHDNCCIHNCIOBSSR | 06/03/20 | 03/17/23 |
Agency: NIH Institutions: OPPNETNIAAANIEHSNIMHNIMHDNCCIHNCIOBSSR | 06/03/20 | 03/17/23 |
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) Agency: NIH Institutions: NCCIHODS | 05/20/20 | 05/07/23 |
NCCIH Natural Product Mid Phase Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) Agency: NIH Institutions: NCCIH | 05/20/20 | 05/07/23 |
Metastasis Research Network (U54 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 05/13/20 | 05/28/21 |
Agency: NIH Institutions: NCCIHNCINHLBINHGRINIANIAAANIBIBNICHDNIDCDNIDCRNIDANIMHNINDSNIEHSNIMHD | 05/12/20 | 05/07/23 |
Agency: NIH | 05/12/20 | 05/07/23 |
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIHNEINHGRINIANIAAANIAIDNIAMSNIDCDNIDCRNIDANIEHSNINRNIMHDNLMNCCIHNCIICs | 05/07/20 | 05/07/23 |
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) Agency: NIH Institutions: NCINHLBINHGRINIANIAAANIAMSNIBIBNICHDNIDANCCIHNIDDKNIEHSNIMHNINDSNINRNIMHD | 05/05/20 | 05/07/23 |
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIHNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIPNCIICs | 05/05/20 | 05/07/23 |
Agency: NIH Institutions: NCINEINIANIAAANICHDNIDCDNIDCRNIDANIEHSNIMHNIMHDNINDSNINRNCCIH | 05/05/20 | 05/07/23 |
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIAIDNIBIBNCCIHNICHDNIDANIDCDNIDCRNIDDKNIEHSNIGMSNIMHNINDSNINRNLMORIPNIMHD | 05/05/20 | 05/07/23 |
Agency: NIH Institutions: ODPNIANIDCDNIDANIMHNINRNIMHDNCCIHNCIOBSSR | 04/30/20 | 09/07/23 |
Agency: NIH Institutions: ODPNIANIDCDNIDCRNCCIHNCI | 04/30/20 | 09/07/23 |
Agency: NIH Institutions: NIMHDNIANIDANCI | 04/20/20 | 09/07/23 |
Agency: NIH Institutions: NCI | 04/15/20 | 06/06/23 |
Agency: NIH Institutions: NCI | 04/14/20 | 06/24/21 |
Agency: NSF | 04/07/20 | 12/01/21 |
Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: NIMHDNHLBINIANIAAANINDSNCI | 04/03/20 | 07/14/22 |
Agency: NIH Institutions: NCINIBIBNIDCR | 03/30/20 | 09/07/22 |
NIDA Small Research Grant Program (R03 Clinical Trial Required) Agency: NIH Institutions: NIDA | 03/24/20 | 05/07/23 |
Agency: NIH Institutions: NIDA | 03/24/20 | 08/13/21 |
Agency: NIH Institutions: NCINEINHGRINHLBINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDDKNIDANIEHSNIGMSNIMHNINRNCCIHORIP | 03/20/20 | 05/25/23 |
Agency: NIH Institutions: NCI | 03/16/20 | 07/30/21 |
Agency: NIH Institutions: NCI | 03/16/20 | 07/30/21 |
Agency: NIH Institutions: NCI | 03/12/20 | 05/07/23 |
Agency: NIH Institutions: NIDDKNCI | 03/11/20 | 06/08/21 |
Agency: NIH Institutions: NIDDKNCI | 03/11/20 | 06/08/21 |
Agency: NIH Institutions: NCINCCIHNHGRINIAIDNICHDNIDDKNIEHSNIGMSNIMH | 03/10/20 | 09/07/25 |
Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID | 03/06/20 | 01/07/22 |
Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional) Agency: NIH Institutions: NIGMSNCINHLBINHGRINIANIAIDNIAMSNIDCRNIDDKNIDANIMHDNCCIHORWH | 03/05/20 | 07/23/21 |
Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 02/24/20 | 11/18/21 |
Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAIDNCINHLBINIANICHDNIDCRNIDDKNIDANIMHNINRNIMHDFIC | 02/03/20 | 07/28/22 |
Centers for AIDS Research (P30 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAIDNCINHLBINIANICHDNIDCRNIDDKNIDANIMHNINRNIMHDFIC | 02/03/20 | 07/28/22 |
National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) Agency: NIH Institutions: NCI | 01/27/20 | 05/07/23 |
Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed) Agency: NIH Institutions: NICHDNEINIMHNINDSNCI | 01/23/20 | 05/26/22 |
Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed) Agency: NIH Institutions: NIGMSNIAAANIAIDNIDANIEHSNINDSNIMHDNCI | 01/17/20 | 05/08/23 |
Biomedical Data Repository (U24 - Clinical Trials Not Allowed) Agency: NIH Institutions: NIGMSNIAAANIAIDNIDANIEHSNINDSNIMHDNCI | 01/17/20 | 05/08/23 |
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01- Clinical Trial Not Allowed) Agency: NIH Institutions: NIMHDNCI | 01/14/20 | 04/01/22 |
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21- Clinical Trial Not Allowed) Agency: NIH Institutions: NIMHDNCI | 01/14/20 | 04/01/22 |
Agency: NIH Institutions: NCI | 12/10/19 | 10/28/22 |
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID | 12/09/19 | 09/07/22 |
Co-infection and Cancer (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 11/22/19 | 01/07/23 |
Co-infection and Cancer (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 11/22/19 | 01/07/23 |
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID | 11/22/19 | 01/07/23 |
Agency: NIH Institutions: NCI | 11/12/19 | 01/07/23 |
Agency: NIH Institutions: NIAID | 11/12/19 | 05/11/21 |
Agency: NIH Institutions: NCI | 11/08/19 | 01/07/23 |
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) Agency: NIH Institutions: NCI | 11/04/19 | 09/25/22 |
Integrative Research on Polysubstance Abuse and Disorder (R61/R33 Clinical Trial Optional) Agency: NIH Institutions: NIDANCI | 10/18/19 | 11/07/22 |
Agency: NIH Institutions: NCI | 10/18/19 | 01/07/23 |
Agency: NIH Institutions: NINDSNEINHLBINIANIAAANIAMSNIBIBNICHDNIDCRNIDDKNIGMSNIMHNINRNIMHDNLMNCCIHNCATSORIPNCI | 10/04/19 | 09/08/22 |
Agency: NIH Institutions: NINDSNEINHLBINIANIAAANIBIBNICHDNIDDKNIGMSNIMHNINRNIMHDNCCIHNCI | 10/04/19 | 09/08/22 |
Agency: NIH Institutions: NINDSNEINHLBINIANIAAANIBIBNICHDNIDDKNIGMSNIMHNINRNIMHDNCCIHNCI | 10/04/19 | 09/08/22 |
Agency: NIH Institutions: NINDSNEINHLBINIANIAAANIAMSNIBIBNICHDNIDCRNIDDKNIGMSNIMHNINRNIMHDNLMNCCIHNCATSORIPNCI | 10/04/19 | 09/08/22 |
Agency: NIH Institutions: NCI | 10/02/19 | 01/07/23 |
Agency: NIH Institutions: NCINIBIB | 10/02/19 | 01/07/23 |
Agency: NIH Institutions: NICHDNHLBINIDCRNCI | 09/12/19 | 01/07/23 |
Agency: NIH Institutions: NHLBINCINIANIAID | 09/09/19 | 01/14/22 |
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDANIAAA | 09/09/19 | 09/07/21 |
Revision Applications for Mechanisms of Drug Resistance (U54 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI | 09/06/19 | 06/23/21 |
Revision Applications for Mechanisms of Drug Resistance (P01 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI | 09/05/19 | 06/23/21 |
Revision Applications for Mechanisms of Drug Resistance (P50 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI | 09/05/19 | 06/23/21 |
Revision Applications for Mechanisms of Drug Resistance (R01 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI | 09/05/19 | 06/23/21 |
Revision Applications for Mechanisms of Drug Resistance (U01 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI | 09/05/19 | 06/23/21 |
Agency: NIH Institutions: NCI | 09/05/19 | 09/07/21 |
Agency: NIH Institutions: NIAID | 09/03/19 | 01/10/22 |
Agency: NIH Institutions: NIAID | 09/03/19 | 01/10/22 |
Agency: NIH Institutions: NCI | 08/29/19 | 03/11/22 |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional) Agency: NIH Institutions: NCI | 08/29/19 | 07/16/22 |
Agency: NIH Institutions: NCI | 08/29/19 | 09/07/22 |
Agency: NIH Institutions: NCI | 08/29/19 | 09/07/22 |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI | 08/29/19 | 09/07/22 |
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI | 08/29/19 | 09/07/22 |
Neural Regulation of Cancer (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 08/28/19 | 05/27/22 |
Neural Regulation of Cancer (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 08/28/19 | 05/27/22 |
Agency: NIH Institutions: NIAID | 08/16/19 | 07/16/22 |
Agency: NIH Institutions: NCI | 08/16/19 | 06/08/22 |
Agency: NIH Institutions: NCI | 08/16/19 | 06/08/22 |
Agency: NIH Institutions: NIAID | 08/16/19 | 09/07/22 |
Agency: NIH Institutions: NCI | 08/12/19 | 06/08/22 |
Agency: NIH Institutions: NCI | 08/12/19 | 06/08/22 |
Agency: NIH Institutions: NCI | 07/30/19 | 02/11/22 |
Agency: NIH Institutions: ODPNCINHLBINIAAANIDANIEHSCTP | 07/08/19 | 03/08/21 |
Agency: NIH Institutions: NCI | 06/28/19 | 09/07/22 |
Agency: NIH Institutions: NIA | 06/25/19 | 07/16/22 |
Agency: NIH Institutions: NIA | 06/25/19 | 07/16/22 |
Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI | 05/22/19 | 11/15/21 |
Postdoctoral Research Associate Training (PRAT) Program (Fi2) Agency: NIH Institutions: NIGMS | 05/21/19 | 10/04/21 |
Agency: NIH Institutions: FICNCINIDANIMH | 05/14/19 | 08/20/21 |
Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI | 05/08/19 | 10/08/21 |
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINHGRINIANIAAANICHDNIDCRNIDANIEHSNIMHNINDSFICODPOBSSRORWH | 05/08/19 | 05/07/22 |
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINHLBINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDANIEHSNIMHNINDSNINRNIMHDNCCIHODPOBSSRORWH | 05/08/19 | 05/07/22 |
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINHGRINIANIAAANIAIDNIAMSNIDCDNIDANIEHSNIMHNINDSNINRFICNCCIHODPOBSSRORWH | 05/08/19 | 05/07/22 |
Agency: NIH Institutions: NCI | 05/01/19 | 12/10/21 |
Agency: NIH Institutions: NCINIEHS | 04/11/19 | 11/08/21 |
Agency: NIH Institutions: NCINIEHS | 04/11/19 | 11/08/21 |
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Agency: NIH Institutions: NCI | 04/08/19 | 06/17/21 |
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional) Agency: NIH Institutions: NCCIHNCINIANIAAANIDANIDCRNINDSNINROBSSRORWH | 02/28/19 | 05/07/22 |
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional) Agency: NIH Institutions: NCCIHNCINHLBINIANIAAANIDANIDCRNINDSNINROBSSRORWH | 02/28/19 | 05/07/22 |
Agency: NIH Institutions: NCI | 02/27/19 | 11/08/21 |
Agency: NIH Institutions: NCI | 02/27/19 | 11/08/21 |
Microbial-based Cancer Therapy -Bugs as Drugs (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 02/22/19 | 05/07/22 |
Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 02/22/19 | 05/07/22 |
Biology of Bladder Cancer (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI | 02/05/19 | 05/07/22 |
Biology of Bladder Cancer (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI | 02/05/19 | 05/07/22 |
Agency: NIH Institutions: NIDANIMHDNIMHNCINCCIHORWH | 01/09/19 | 09/07/21 |
Agency: NIH Institutions: NIDANINDSNIMHDNIMHNCINICHDORWH | 01/09/19 | 09/07/21 |
Bioengineering Research Grants (BRG) (R01 Clinical Trial Required) Agency: NIH Institutions: NIBIBNCINIANIAAANINDS | 01/08/19 | 05/07/21 |
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIBIBNIAAANIAMSNCINIDCRNIEHSNINDSNIA | 01/08/19 | 01/07/22 |
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI | 01/08/19 | 01/07/22 |
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINIAMS | 01/08/19 | 01/07/22 |
Agency: NIH Institutions: NINRNCI | 01/08/19 | 01/07/22 |
Agency: NIH Institutions: NICHDNEININRNIDCDNIDANINDSNHLBINCINIANIMH | 12/21/18 | 01/07/22 |
Agency: NIH Institutions: NINRNCI | 12/21/18 | 01/07/22 |
Agency: NIH Institutions: NINRNCINIANICHDNIDCDNIDANIMHNINDSNHLBI | 12/21/18 | 01/07/22 |
Agency: NIH Institutions: NIDCRNCINHLBINIANIAIDNIAMSNIBIBNICHDNIDCDNIDANIEHSNIMHNINDSNCCIHNINR | 12/21/18 | 01/07/22 |
Agency: NIH Institutions: NCI | 12/17/18 | 01/07/22 |
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI | 12/17/18 | 01/07/22 |
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI | 12/17/18 | 01/07/22 |
Agency: NIH Institutions: NIMHDNCIOBSSR | 11/28/18 | 03/04/21 |
Agency: NIH Institutions: NIDCRNCINIMHNLMNCATS | 10/24/18 | 09/05/21 |
Agency: NIH Institutions: NIDCRNCINIMHNLMNCATS | 10/24/18 | 09/05/21 |
Agency: NIH Institutions: NIMHDNCI | 10/05/18 | 03/04/21 |
Agency: NIH Institutions: NIMHDNCI | 10/05/18 | 03/04/21 |
Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINEINHLBINHGRINIAAANIAMSNIBIBNIDCDNIDCRNIDANIMHNINDSNCCIHODSORWH | 10/05/18 | 04/15/21 |
Agency: NIH Institutions: NINRNCINCCIHOBSSR | 10/01/18 | 01/07/22 |
Agency: NIH Institutions: NINRNCINCCIHOBSSR | 10/01/18 | 01/07/22 |
Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional) Agency: NIH Institutions: NINRNCINIAMSNCCIHOBSSR | 10/01/18 | 01/07/22 |
Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional) Agency: NIH Institutions: NINRNCINIAMSNCCIHOBSSR | 10/01/18 | 01/07/22 |
Agency: NIH Institutions: NCI | 09/28/18 | 07/11/21 |
Agency: NIH Institutions: ODPNCINIANIAAANIDCRNIDANIMHNIMHD | 09/21/18 | 01/07/22 |
Agency: NIH Institutions: NIDANCINCCIHNIAAANICHD | 09/10/18 | 09/07/21 |
Agency: NIH Institutions: NCI | 09/07/18 | 08/11/21 |
Agency: NIH Institutions: NCINCCIHODS | 08/14/18 | 09/07/21 |
Agency: NIH Institutions: NCI | 08/07/18 | 09/07/21 |
Agency: NIH Institutions: NCI | 08/07/18 | 09/07/21 |
Agency: NIH Institutions: NIDCRNCINIAMSNIDAODS | 07/25/18 | 09/07/21 |
Agency: NIH Institutions: NIDCRNIMHD | 07/25/18 | 09/07/21 |
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI | 07/24/18 | 03/08/21 |
Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDDKNCINIAAANIMHDNCCIH | 07/17/18 | 09/07/21 |
Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDDKNCINIAAANIMHDNINR | 07/17/18 | 09/07/21 |
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDDKNCINICHDODPOBSSR | 07/12/18 | 09/10/21 |
Agency: NIH Institutions: ODPNCINIDCRNIDANIEHS | 06/29/18 | 06/25/21 |
Agency: NIH Institutions: ODPNCINIDCRNIDANIMHD | 06/29/18 | 06/25/21 |
Agency: NIH Institutions: ODPNCINIDCRNIDANIMHD | 06/29/18 | 06/15/21 |
Agency: NIH Institutions: ODPNCINIDCRNIDANIEHS | 06/29/18 | 06/15/21 |
Agency: NIH Institutions: NCI | 06/28/18 | 06/14/21 |
Agency: NIH Institutions: NCINEINHGRINIANIAAANIAIDNIBIBNIDCRNIDANIGMSNINDSNINRNIMHDNCCIHNCATS | 06/20/18 | 09/04/21 |
The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: NICHDNCINEI | 06/14/18 | 06/03/21 |
Precision Imaging of Oral Lesions (R01- Clinical Trial Not Allowed) Agency: NIH Institutions: NIDCRNIBIBNCI | 05/16/18 | 09/07/21 |
Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional) Agency: NIH Institutions: NIAIDNCINIMH | 04/20/18 | 05/07/21 |
Agency: NIH Institutions: NCINIANIDCRNINR | 04/03/18 | 05/07/21 |
Agency: NIH Institutions: NCINIANIDCRNINR | 04/03/18 | 05/07/21 |
Agency: NIH Institutions: OBSSRNCINIANIAAANIAIDNIDANIMHNINRNIMHD | 03/28/18 | 05/07/21 |
Agency: NIH Institutions: OBSSRNCINIANIAAANIAIDNIDANIMHNINRNIMHDNCCIH | 03/28/18 | 05/07/21 |
SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed) Agency: NIH Institutions: NINDSNCINEINIAAANIDCRNIDANINR | 03/06/18 | 04/05/21 |
Agency: NIH Institutions: NCI | 02/23/18 | 05/07/21 |
Agency: NIH Institutions: NCI | 02/23/18 | 05/07/21 |
Change of Grantee Organization (Type 7 Parent Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH | 01/25/18 | 04/30/21 |
Agency: NIH Institutions: ORWHNCINEINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIP | 01/25/18 | 09/07/21 |
Agency: NIH Institutions: NCINIDCRNIBIB | 12/21/17 | 05/07/21 |
Agency: NIH Institutions: NCI | 12/11/17 | 05/07/21 |
Agency: NIH Institutions: NCI | 12/11/17 | 05/07/21 |
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCI | 12/06/17 | 03/12/21 |
The NCI Transition Career Development Award (K22 Independent Clinical Trial Required) Agency: NIH Institutions: NCI | 12/06/17 | 03/12/21 |
NCI Transition Career Development Award to Promote Diversity (K22 - No Clinical Trials) Agency: NIH Institutions: NCI | 11/20/17 | 05/07/21 |
NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) Agency: NIH Institutions: NCI | 11/20/17 | 05/07/21 |
NCI Mentored Research Scientist Development Award to Promote Diversity (K01) Agency: NIH Institutions: NCI | 11/17/17 | 05/07/21 |
NCI Mentored Research Scientist Development Award to Promote Diversity (K01) Agency: NIH Institutions: NCI | 11/17/17 | 05/07/21 |
Mechanisms, Models, Measurement, and Management in Pain Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NINRNIANIDDKNIDANIDCRNINDSNCCIHNIMHDNCI | 11/07/17 | 05/07/21 |
Mechanisms, Models, Measurement, and Management in Pain Research (R21 Clinical Trial Optional) Agency: NIH Institutions: NCININRNIANIDANIDCRNINDSNCCIHNIMHD | 11/07/17 | 05/07/21 |
Agency: NIH Institutions: NCI | 10/31/17 | 05/07/21 |
Agency: NIH Institutions: NCI | 10/31/17 | 05/07/21 |
Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIANIAAANICHDNIDANIMHDNCCIH | 10/17/17 | 05/07/21 |
Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIANIAAANIDANCCIH | 10/10/17 | 05/07/21 |
Fundamental Research to Counter Weapons of Mass Destruction Agency: DTRA | 03/20/15 | 09/30/24 |